Company news

Sumitomo Pharma Co.Ltd. news in 2025

Sumitomo Pharma Co.Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Sumitomo Pharma America Presents New Investigational Data on Enzomenib and Nuvisertib at the 2025 American Society of Hematology Annual Meeting and Exposition

December 8, 2025

Sumitomo Pharma America to Present New Investigational Data at the 2025 American Society of Hematology Annual Meeting

November 3, 2025

Sumitomo Pharma America Announces that the European Medicines Agency Has Granted Orphan Drug Designation to Nuvisertib (TP-3654) for the Treatment of Myelofibrosis

July 30, 2025

Sumitomo Pharma America and Former Professional Quarterback Rodney Peete Say it's Time to Go™ and Put Yourself First with Overactive Bladder Treatment Option GEMTESA®

June 30, 2025

Calls in 2025

Decks in 2025